Jazz Pharmaceuticals plc Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
Jazz Pharmaceuticals plc (JAZZ) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $458.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2018-05-08
- Jazz Pharmaceuticals plc other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2018-03-31 was $458.00K.
- Jazz Pharmaceuticals plc other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-09-30 was $56.00K.
- Jazz Pharmaceuticals plc other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-06-30 was -$104.00K.
- Jazz Pharmaceuticals plc other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-03-31 was -$89.00K.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month |
|---|---|---|---|
| 2018-03-31 | $458.00K 10-Q · filed 2018-05-08 | ||
| 2017-09-30 | $56.00K 10-Q · filed 2017-11-07 | -$48.00K derived: sum of 2 quarters · filed 2017-11-07 | -$137.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$104.00K 10-Q · filed 2017-08-08 | -$193.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$89.00K 10-Q · filed 2018-05-08 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |